APO Research
Talk to an analyst

APO RESEARCH · REPORT

Pentanediamine

Diaminopentane, also known as Cadaverine, 1,5-diaminopentane, pentamethylene diamine or cadaverine, is a biological amine (including putrescine, spermine, spermidine and Cadaverine, etc.). Pentanediamine has a wide range of applications in agriculture, medicine and industry.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Diaminopentane, also known as Cadaverine, 1,5-diaminopentane, pentamethylene diamine or cadaverine, is a biological amine (including putrescine, spermine, spermidine and Cadaverine, etc.). Pentanediamine has a wide range of applications in agriculture, medicine and industry.

Selected research

Market Outlook & Growth Opportunities

Global Pentanediamine Market Outlook and Growth Opportunities 2026

28 December 2025191 pages

Choose your research edition.

Industry ResearchPentanediamine Industry Research Report 2026109 pages · $2,950 USDIndustry Growth & TrendsGlobal Pentanediamine Industry Growth and Trends Forecast to 203276 pages · $3,450 USDMarket StructureGlobal Pentanediamine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032174 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pentanediamine Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Pentanediamine Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

Diaminopentane, also known as Cadaverine, 1,5-diaminopentane, pentamethylene diamine or cadaverine, is a biological amine (including putrescine, spermine, spermidine and Cadaverine, etc.). Pentanediamine has a wide range of applications in agriculture, medicine and industry.

In general, almost all polyamide companies have invested heavily in bio-based polyamides. The leading giants are Arkema, BASF, DuPont, Jinfa Technology, EMS, Evonik and other companies. With the intensification of market competition, the industry's capital threshold and technology threshold are obviously higher. Therefore, how to quickly seize the market is also very important.

This report provides an overview of the global Pentanediamine market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

Read the full market overview

The study covers key producers of Pentanediamine and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Pentanediamine sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Pentanediamine market size, projected growth trends, production technologies, key applications, and end-use industries.

Pentanediamine Segment by Company

Kaiser Bio

Ningxia Yipin Biotechnology Co., Ltd.

Toray

Pentanediamine Segment by Type

Bio-based Polyamide (Nylon)

Other

Pentanediamine Segment by Application

Agriculture

Medicine

Industry

Other

Pentanediamine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Pentanediamine status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Pentanediamine market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Pentanediamine significant trends, drivers, influence factors in global and regions.

6. To analyze Pentanediamine competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pentanediamine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pentanediamine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pentanediamine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Pentanediamine market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Pentanediamine industry.

Chapter 3: Detailed analysis of Pentanediamine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Pentanediamine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Pentanediamine in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Pentanediamine Industry Trends Table 2. Pentanediamine Industry Drivers Table 3. Pentanediamine Industry Opportunities and Challenges Table 4. Pentanediamine Industry Restraints Table 5. Global Pentanediamine Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Pentanediamine Revenue Share by Company (2021-2026) Table 7. Global Pentanediamine Sales Volume by Company (Kiloton) & (2021-2026) Table 8. Global Pentanediamine Sales Volume Share by Company (2021-2026) Table 9. Global Pentanediamine Average Price (US$/Ton) of Company (2021-2026) Table 10. Global Pentanediamine Company Ranking, (2024-2026) & (USD Million) Table 11. Global Pentanediamine Key Company Manufacturing Base & Headquarters Table 12. Global Pentanediamine Company, Product Type & Application Table 13. Global Pentanediamine Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Pentanediamine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Bio-based Polyamide (Nylon) Table 18. Significant Companies of Other Table 19. Global Pentanediamine Sales Volume by Type 2021 VS 2025 VS 2032 (Kiloton) Table 20. Global Pentanediamine Sales Volume by Type (2021-2026) & (Kiloton) Table 21. Global Pentanediamine Sales Volume by Type (2027-2032) & (Kiloton) Table 22. Global Pentanediamine Sales Volume Share by Type (2021-2026) Table 23. Global Pentanediamine Sales Volume Share by Type (2027-2032) Table 24. Global Pentanediamine Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Pentanediamine Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Pentanediamine Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Pentanediamine Sales Value Share by Type (2021-2026) Table 28. Global Pentanediamine Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Agriculture Table 30. Significant Companies of Medicine Table 31. Significant Companies of Industry Table 32. Significant Companies of Other Table 33. Global Pentanediamine Sales Volume by Application 2021 VS 2025 VS 2032 (Kiloton) Table 34. Global Pentanediamine Sales Volume by Application (2021-2026) & (Kiloton) Table 35. Global Pentanediamine Sales Volume by Application (2027-2032) & (Kiloton) Table 36. Global Pentanediamine Sales Volume Share by Application (2021-2026) Table 37. Global Pentanediamine Sales Volume Share by Application (2027-2032) Table 38. Global Pentanediamine Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Pentanediamine Sales Value by Application (2021-2026) & (US$ Million) Table 40. Global Pentanediamine Sales Value by Application (2027-2032) & (US$ Million) Table 41. Global Pentanediamine Sales Value Share by Application (2021-2026) Table 42. Global Pentanediamine Sales Value Share by Application (2027-2032) Table 43. Global Pentanediamine Sales by Region: 2021 VS 2025 VS 2032 (Kiloton) Table 44. Global Pentanediamine Sales by Region (2021-2026) & (Kiloton) Table 45. Global Pentanediamine Sales Market Share by Region (2021-2026) Table 46. Global Pentanediamine Sales by Region (2027-2032) & (Kiloton) Table 47. Global Pentanediamine Sales Market Share by Region (2027-2032) Table 48. Global Pentanediamine Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Pentanediamine Sales Value by Region (2021-2026) & (US$ Million) Table 50. Global Pentanediamine Sales Value Share by Region (2021-2026) Table 51. Global Pentanediamine Sales Value by Region (2027-2032) & (US$ Million) Table 52. Global Pentanediamine Sales Value Share by Region (2027-2032) Table 53. Global Pentanediamine Market Average Price (US$/Ton) by Region (2021-2026) Table 54. Global Pentanediamine Market Average Price (US$/Ton) by Region (2027-2032) Table 55. Global Pentanediamine Sales by Country: 2021 VS 2025 VS 2032 (Kiloton) Table 56. Global Pentanediamine Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 57. Global Pentanediamine Sales by Country (2021-2026) & (Kiloton) Table 58. Global Pentanediamine Sales Market Share by Country (2021-2026) Table 59. Global Pentanediamine Sales by Country (2027-2032) & (Kiloton) Table 60. Global Pentanediamine Sales Market Share by Country (2027-2032) Table 61. Global Pentanediamine Sales Value by Country (2021-2026) & (US$ Million) Table 62. Global Pentanediamine Sales Value Market Share by Country (2021-2026) Table 63. Global Pentanediamine Sales Value by Country (2027-2032) & (US$ Million) Table 64. Global Pentanediamine Sales Value Market Share by Country (2027-2032) Table 65. Kaiser Bio Company Information Table 66. Kaiser Bio Business Overview Table 67. Kaiser Bio Pentanediamine Sales (Kiloton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 68. Kaiser Bio Pentanediamine Product Portfolio Table 69. Kaiser Bio Recent Development Table 70. Ningxia Yipin Biotechnology Co., Ltd. Company Information Table 71. Ningxia Yipin Biotechnology Co., Ltd. Business Overview Table 72. Ningxia Yipin Biotechnology Co., Ltd. Pentanediamine Sales (Kiloton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 73. Ningxia Yipin Biotechnology Co., Ltd. Pentanediamine Product Portfolio Table 74. Ningxia Yipin Biotechnology Co., Ltd. Recent Development Table 75. Toray Company Information Table 76. Toray Business Overview Table 77. Toray Pentanediamine Sales (Kiloton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 78. Toray Pentanediamine Product Portfolio Table 79. Toray Recent Development Table 80. Key Raw Materials Table 81. Raw Materials Key Suppliers Table 82. Pentanediamine Distributors List Table 83. Pentanediamine Customers List Table 84. Research Programs/Design for This Report Table 85. Authors List of This Report Table 86. Secondary Sources Table 87. Primary Sources List of Figures Figure 1. Pentanediamine Product Image Figure 2. Global Pentanediamine Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pentanediamine Sales Value (2021-2032) & (US$ Million) Figure 4. Global Pentanediamine Sales (2021-2032) & (Kiloton) Figure 5. Global Pentanediamine Sales Average Price (US$/Ton) & (2021-2032) Figure 6. Global Pentanediamine Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Bio-based Polyamide (Nylon) Image Figure 10. Other Image Figure 11. Global Pentanediamine Sales Volume by Type (2021 VS 2025 VS 2032) & (Kiloton) Figure 12. Global Pentanediamine Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Pentanediamine Sales Volume Share by Type (2021-2032) Figure 14. Global Pentanediamine Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Pentanediamine Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Pentanediamine Sales Value Share by Type (2021-2032) Figure 17. Agriculture Image Figure 18. Medicine Image Figure 19. Industry Image Figure 20. Other Image Figure 21. Global Pentanediamine Sales Volume by Application (2021 VS 2025 VS 2032) & (Kiloton) Figure 22. Global Pentanediamine Sales Volume Share 2021 VS 2025 VS 2032 Figure 23. Global Pentanediamine Sales Volume Share by Application (2021-2032) Figure 24. Global Pentanediamine Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Pentanediamine Sales Value Share 2021 VS 2025 VS 2032 Figure 26. Global Pentanediamine Sales Value Share by Application (2021-2032) Figure 27. Global Pentanediamine Sales by Region: 2021 VS 2025 VS 2032 (Kiloton) Figure 28. Global Pentanediamine Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 29. Global Pentanediamine Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 30. Global Pentanediamine Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 31. North America Pentanediamine Sales Value (2021-2032) & (US$ Million) Figure 32. North America Pentanediamine Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Europe Pentanediamine Sales Value (2021-2032) & (US$ Million) Figure 34. Europe Pentanediamine Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Asia-Pacific Pentanediamine Sales Value (2021-2032) & (US$ Million) Figure 36. Asia-Pacific Pentanediamine Sales Value Share by Country (%), 2025 VS 2032 Figure 37. South America Pentanediamine Sales Value (2021-2032) & (US$ Million) Figure 38. South America Pentanediamine Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Middle East & Africa Pentanediamine Sales Value (2021-2032) & (US$ Million) Figure 40. Middle East & Africa Pentanediamine Sales Value Share by Country (%), 2025 VS 2032 Figure 41. USA Pentanediamine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. USA Pentanediamine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. USA Pentanediamine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Canada Pentanediamine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Canada Pentanediamine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Canada Pentanediamine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Mexico Pentanediamine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Mexico Pentanediamine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Mexico Pentanediamine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Germany Pentanediamine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Germany Pentanediamine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Germany Pentanediamine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. France Pentanediamine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. France Pentanediamine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. France Pentanediamine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. U.K. Pentanediamine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. U.K. Pentanediamine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. U.K. Pentanediamine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Italy Pentanediamine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Italy Pentanediamine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Italy Pentanediamine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Spain Pentanediamine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Spain Pentanediamine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Spain Pentanediamine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Russia Pentanediamine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Russia Pentanediamine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Russia Pentanediamine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Netherlands Pentanediamine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Netherlands Pentanediamine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Netherlands Pentanediamine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Nordic Countries Pentanediamine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Nordic Countries Pentanediamine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Nordic Countries Pentanediamine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. China Pentanediamine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. China Pentanediamine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. China Pentanediamine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Japan Pentanediamine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Japan Pentanediamine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Japan Pentanediamine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. South Korea Pentanediamine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. South Korea Pentanediamine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. South Korea Pentanediamine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. India Pentanediamine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. India Pentanediamine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. India Pentanediamine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Australia Pentanediamine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Australia Pentanediamine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Australia Pentanediamine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Southeast Asia Pentanediamine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Southeast Asia Pentanediamine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Southeast Asia Pentanediamine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Brazil Pentanediamine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Brazil Pentanediamine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Brazil Pentanediamine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Argentina Pentanediamine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Argentina Pentanediamine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Argentina Pentanediamine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Chile Pentanediamine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Chile Pentanediamine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Chile Pentanediamine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Colombia Pentanediamine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Colombia Pentanediamine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Colombia Pentanediamine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Peru Pentanediamine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Peru Pentanediamine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Peru Pentanediamine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Pentanediamine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Saudi Arabia Pentanediamine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Pentanediamine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Israel Pentanediamine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Israel Arabia Pentanediamine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Israel Arabia Pentanediamine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. UAE Pentanediamine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. UAE Pentanediamine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. UAE Pentanediamine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Turkey Pentanediamine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Turkey Pentanediamine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Turkey Pentanediamine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Iran Pentanediamine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Iran Pentanediamine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Iran Pentanediamine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Egypt Pentanediamine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Egypt Pentanediamine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Egypt Pentanediamine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Pentanediamine Value Chain Figure 126. Manufacturing Cost Structure Figure 127. Pentanediamine Sales Mode & Process Figure 128. Direct Comparison with Distribution Share Figure 129. Distributors Profiles Figure 130. Years Considered Figure 131. Research Process Figure 132. Key Executives Interviewed

Scope & coverage.

Types
  • Bio-based Polyamide (Nylon)
  • Other
Applications
  • Agriculture
  • Medicine
  • Industry
  • Other
Companies covered
  • Kaiser Bio
  • Ningxia Yipin Biotechnology Co., Ltd.
  • Toray

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Pentanediamine Sales Value (2021-2032)
  4. 1.2.2 Global Pentanediamine Sales Volume (2021-2032)
  5. 1.2.3 Global Pentanediamine Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Pentanediamine Market Dynamics
  1. 2.1 Pentanediamine Industry Trends
  2. 2.2 Pentanediamine Industry Drivers
  3. 2.3 Pentanediamine Industry Opportunities and Challenges
  4. 2.4 Pentanediamine Industry Restraints
3 Pentanediamine Market by Company
  1. 3.1 Global Pentanediamine Company Revenue Ranking in 2025
  2. 3.2 Global Pentanediamine Revenue by Company (2021-2026)
  3. 3.3 Global Pentanediamine Sales Volume by Company (2021-2026)
  4. 3.4 Global Pentanediamine Average Price by Company (2021-2026)
  5. 3.5 Global Pentanediamine Company Ranking (2024-2026)
  6. 3.6 Global Pentanediamine Company Manufacturing Base and Headquarters
  7. 3.7 Global Pentanediamine Company Product Type and Application
  8. 3.8 Global Pentanediamine Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Pentanediamine Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Pentanediamine Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Pentanediamine Market by Type
  1. 4.1 Pentanediamine Type Introduction
  2. 4.1.1 Bio-based Polyamide (Nylon)
  3. 4.1.2 Other
  4. 4.2 Global Pentanediamine Sales Volume by Type
  5. 4.2.1 Global Pentanediamine Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Pentanediamine Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Pentanediamine Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Pentanediamine Sales Value by Type
  9. 4.3.1 Global Pentanediamine Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Pentanediamine Sales Value by Type (2021-2032)
  11. 4.3.3 Global Pentanediamine Sales Value Share by Type (2021-2032)
5 Pentanediamine Market by Application
  1. 5.1 Pentanediamine Application Introduction
  2. 5.1.1 Agriculture
  3. 5.1.2 Medicine
  4. 5.1.3 Industry
  5. 5.1.4 Other
  6. 5.2 Global Pentanediamine Sales Volume by Application
  7. 5.2.1 Global Pentanediamine Sales Volume by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Pentanediamine Sales Volume by Application (2021-2032)
  9. 5.2.3 Global Pentanediamine Sales Volume Share by Application (2021-2032)
  10. 5.3 Global Pentanediamine Sales Value by Application
  11. 5.3.1 Global Pentanediamine Sales Value by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Pentanediamine Sales Value by Application (2021-2032)
  13. 5.3.3 Global Pentanediamine Sales Value Share by Application (2021-2032)
6 Pentanediamine Regional Sales and Value Analysis
  1. 6.1 Global Pentanediamine Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Pentanediamine Sales by Region (2021-2032)
  3. 6.2.1 Global Pentanediamine Sales by Region: 2021-2026
  4. 6.2.2 Global Pentanediamine Sales by Region (2027-2032)
  5. 6.3 Global Pentanediamine Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Pentanediamine Sales Value by Region (2021-2032)
  7. 6.4.1 Global Pentanediamine Sales Value by Region: 2021-2026
  8. 6.4.2 Global Pentanediamine Sales Value by Region (2027-2032)
  9. 6.5 Global Pentanediamine Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Pentanediamine Sales Value (2021-2032)
  12. 6.6.2 North America Pentanediamine Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Pentanediamine Sales Value (2021-2032)
  15. 6.7.2 Europe Pentanediamine Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Pentanediamine Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Pentanediamine Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Pentanediamine Sales Value (2021-2032)
  21. 6.9.2 South America Pentanediamine Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Pentanediamine Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Pentanediamine Sales Value Share by Country, 2025 VS 2032
7 Pentanediamine Country-level Sales and Value Analysis
  1. 7.1 Global Pentanediamine Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Pentanediamine Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Pentanediamine Sales by Country (2021-2032)
  4. 7.3.1 Global Pentanediamine Sales by Country (2021-2026)
  5. 7.3.2 Global Pentanediamine Sales by Country (2027-2032)
  6. 7.4 Global Pentanediamine Sales Value by Country (2021-2032)
  7. 7.4.1 Global Pentanediamine Sales Value by Country (2021-2026)
  8. 7.4.2 Global Pentanediamine Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Pentanediamine Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Pentanediamine Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Pentanediamine Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Pentanediamine Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Pentanediamine Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Pentanediamine Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Pentanediamine Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Pentanediamine Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Pentanediamine Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Pentanediamine Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Pentanediamine Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Pentanediamine Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Pentanediamine Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Pentanediamine Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Pentanediamine Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Pentanediamine Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Pentanediamine Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Pentanediamine Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Pentanediamine Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Pentanediamine Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Pentanediamine Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Pentanediamine Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Pentanediamine Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Pentanediamine Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Pentanediamine Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Pentanediamine Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Pentanediamine Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Pentanediamine Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Pentanediamine Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Pentanediamine Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Pentanediamine Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Pentanediamine Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Pentanediamine Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Pentanediamine Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Pentanediamine Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Pentanediamine Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Pentanediamine Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Pentanediamine Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Pentanediamine Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Pentanediamine Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Pentanediamine Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Pentanediamine Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Pentanediamine Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Pentanediamine Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Pentanediamine Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Pentanediamine Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Pentanediamine Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Pentanediamine Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Pentanediamine Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Pentanediamine Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Pentanediamine Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Pentanediamine Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Pentanediamine Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Pentanediamine Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Pentanediamine Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Pentanediamine Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Pentanediamine Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Pentanediamine Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Pentanediamine Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Pentanediamine Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Pentanediamine Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Pentanediamine Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Pentanediamine Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Pentanediamine Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Pentanediamine Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Pentanediamine Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Pentanediamine Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Pentanediamine Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Pentanediamine Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Pentanediamine Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Pentanediamine Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Pentanediamine Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Pentanediamine Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Pentanediamine Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Pentanediamine Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Pentanediamine Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Pentanediamine Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Pentanediamine Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Pentanediamine Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Pentanediamine Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Pentanediamine Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Pentanediamine Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Pentanediamine Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Pentanediamine Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Kaiser Bio
  2. 8.1.1 Kaiser Bio Company Information
  3. 8.1.2 Kaiser Bio Business Overview
  4. 8.1.3 Kaiser Bio Pentanediamine Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Kaiser Bio Pentanediamine Product Portfolio
  6. 8.1.5 Kaiser Bio Recent Developments
  7. 8.2 Ningxia Yipin Biotechnology Co., Ltd.
  8. 8.2.1 Ningxia Yipin Biotechnology Co., Ltd. Company Information
  9. 8.2.2 Ningxia Yipin Biotechnology Co., Ltd. Business Overview
  10. 8.2.3 Ningxia Yipin Biotechnology Co., Ltd. Pentanediamine Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Ningxia Yipin Biotechnology Co., Ltd. Pentanediamine Product Portfolio
  12. 8.2.5 Ningxia Yipin Biotechnology Co., Ltd. Recent Developments
  13. 8.3 Toray
  14. 8.3.1 Toray Company Information
  15. 8.3.2 Toray Business Overview
  16. 8.3.3 Toray Pentanediamine Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Toray Pentanediamine Product Portfolio
  18. 8.3.5 Toray Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Pentanediamine Value Chain Analysis
  2. 9.1.1 Pentanediamine Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Pentanediamine Sales Mode & Process
  6. 9.2 Pentanediamine Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Pentanediamine Distributors
  9. 9.2.3 Pentanediamine Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst